Title: Retracted: ‘Anti‐fibrotic actions of Ghrelin by inhibition of the NADPH oxidase–ROS signaling pathway’ by Qian Wang, Xin Sui, Rui Chen, Peiyong Ma, Tao Ding, Dianjun Sui, and Ping Yang
Abstract:The above article, published online on 17 April 2018 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the authors, the journal Editor in Chief, Prof. Jun-Ping ...The above article, published online on 17 April 2018 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the authors, the journal Editor in Chief, Prof. Jun-Ping Liu, and John Wiley & Sons, Ltd. The authors have withdrawn the paper due to the lack of reproducibility of some of the findings reported in the paper during the consequent experimental work (in particular, the numeric data related to the levels of proteins involved into or responsive to induction of NADPH oxidase pathway). Although these discrepancies do not affect the major conclusions of the paper, the possible presence of incorrect experimental data requires serious revision of the manuscript and thus necessitates the withdrawal of the article.Wang Q, Sui X, Chen R, et al. Anti-fibrotic actions of Ghrelin by inhibition of the NADPH oxidase-ROS signalling pathway. Clin Exp Pharmacol Physiol 2018;00:1-14. https://doi.org/10.1111/1440-1681.12948.Read More
Publication Year: 2018
Publication Date: 2018-04-17
Language: en
Type: retraction
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 2
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot